Company Earnings UpdateCVS Health (CVS) 2Q17 Results: Beats Consensus, Narrows Guidance Range Coresight Research August 9, 2017 Executive Summary CVS Health reported 2Q17 adjusted EPS of $1.33, up 0.7% year over year and beating the $1.31 consensus estimate. Revenues were $45.7 billion, up 4.5% year over year, beating the $45.35 billion consensus estimate. Pharmacy Services was the fastest-growing segment, with revenues up 9.5% year over year, to $32.3 billion. Revenues in the Retail/LTC (Long-Term Care) segment declined by 2.2%. The company narrowed its 2017 adjusted EPS guidance range upward,to $5.83–$5.93 from $5.77–$5.93. Please Login to read the full report. Not a member? To access this content for free, register for a free account. This document was generated for Other research you may be interested in: Rolling Metric Stabilizes: Weekly US Consumer Sentiment, Week 38, 2025—InfographicUS Tariffs: Three Actions for Risk Mitigation and Long-Term PositioningEarnings Insights 1Q25, Week 5: BJ’s Wholesale Club and Home Depot Report Sales Growth; Target Reports Sales Decline—InfographicAgentic Commerce—How Should Retailers Leverage GEO to Maximize AI-Engine Visibility?
